Paul J Norman Selected Research

Amino Acids

1/2019

A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul J Norman Research Topics

Disease

7	Infections 01/2022 - 06/2006
5	Neoplasms (Cancer) 01/2022 - 01/2016
2	Communicable Diseases (Infectious Diseases) 01/2021 - 08/2010
2	Leukemia 01/2021 - 11/2015
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2019
1	COVID-19 01/2022
1	Latent Infection 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Plague (Bubonic Plague) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Neuroinflammatory Diseases 01/2019
1	Behcet Syndrome (Behcet's Syndrome) 01/2019
1	Rheumatoid Arthritis 01/2019
1	Persistent Infection 10/2015
1	Virus Diseases (Viral Diseases) 05/2015
1	Pre-Eclampsia (Preeclampsia) 01/2015
1	Cerebral Malaria 10/2013
1	Malaria 10/2013
1	Disease Resistance 10/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2010

Drug/Important Bio-Agent (IBA)

5	KIR ReceptorsIBA 01/2021 - 06/2006
4	HLA-B Antigens (HLA-B)IBA 01/2021 - 10/2013
3	EpitopesIBA 01/2019 - 01/2015
3	HLA-C Antigens (HLA-C)IBA 11/2015 - 01/2015
3	LigandsIBA 10/2013 - 06/2006
2	HLA-A Antigens (HLA-A)IBA 01/2021 - 01/2019
1	To autoantigenIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	bafilomycin A1IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019
1	Valine (L-Valine)FDA Link 01/2019
1	Amino Acids FDA Link 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Natural Killer Cell ReceptorsIBA 10/2015
1	Histocompatibility Antigens Class IIBA 05/2015

Therapy/Procedure

6	Transplantation 01/2022 - 08/2010
2	Immunotherapy 01/2022 - 08/2016
1	Cell Transplantation 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2016